Louis Fries Selected Research

Immunoglobulin G (IgG)

1/2024	Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.
7/2023	A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.
1/2023	Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
1/2023	Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial.
12/2020	Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis Fries Research Topics

Disease

13	Human Influenza (Influenza) 11/2022 - 01/2006
9	COVID-19 12/2023 - 12/2020
2	Virus Diseases (Viral Diseases) 01/2024 - 01/2021
2	Infections 01/2023 - 08/2014
2	Malaria 12/2022 - 01/2021
1	Asymptomatic Diseases 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	Influenza in Birds (Avian Flu) 07/2015
1	Anaphylaxis (Anaphylactic Shock) 08/2011
1	Injection Site Reaction 06/2011
1	Pain (Aches) 06/2011
1	Rhinorrhea 01/2006

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 07/2023 - 01/2006
7	NVX-CoV2373 adjuvated lipid nanoparticleIBA 12/2023 - 12/2020
7	AntigensIBA 01/2021 - 01/2006
6	Matrix-MIBA 12/2023 - 01/2021
5	Immunoglobulin G (IgG)IBA 01/2024 - 12/2020
5	AntibodiesIBA 01/2023 - 01/2006
5	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2014 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2021
2	Recombinant ProteinsIBA 01/2023 - 01/2023
2	AS03 adjuvantIBA 01/2013 - 08/2011
1	Messenger RNA (mRNA)IBA 01/2024
1	SaponinsIBA 12/2023
1	Subunit VaccinesIBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 02/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2023
1	Nucleocapsid ProteinsIBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Rabies Vaccines (Rabies Vaccine)FDA Link 12/2022
1	rabivaxIBA 12/2022
1	asparaginyl-prolineIBA 01/2021
1	NanovaccinesIBA 01/2018
1	EpitopesIBA 07/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2014
1	Bacterial Outer Membrane ProteinsIBA 03/2011
1	Detergents (Detergent)IBA 03/2011
1	fluarixIBA 11/2008
1	FluLavalIBA 11/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2006
1	Secretory Immunoglobulin A (SIgA)IBA 01/2006

Therapy/Procedure

1	Intranasal Administration 01/2006